Literature DB >> 27357515

Human papillomavirus and lung cancinogenesis: an overview.

Antonio Carlos de Freitas1, Ana Pavla Gurgel2, Elyda Golçalves de Lima2, Bianca de França São Marcos2, Carolina Maria Medeiros do Amaral2.   

Abstract

Lung cancer is the most common cause of cancer deaths worldwide. Although tobacco smoking is considered to be the main risk factor and the most well-established risk factor for lung cancer, a number of patients who do not smoke have developed this disease. This number varies between 15 % to over one-half of lung cancer cases, and the deaths from lung cancer in non-smokers are increasing every year. There are many other agents that are thought to be etiological, including diesel exhaust exposure, metals, radiation, radon, hormonal factors, cooking oil, air pollution and infectious diseases, such as human papillomavirus (HPV). Studies in various parts of the world have detected HPV DNA at different rates in lung tumors. However, the role of HPV in lung cancer is still unclear. Thus, in this review, we investigated some molecular mechanisms of HPV protein activity in host cells, the entry of HPV into lung tissue and the possible route used by the virus to reach the lung cells.

Entities:  

Keywords:  E6 HPV; E7 HPV; Human papillomavirus; Lung cancer; Molecular mechanism

Mesh:

Year:  2016        PMID: 27357515     DOI: 10.1007/s00432-016-2197-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  129 in total

1.  Detection of human papillomaviruses type 16, 18 and 33 in bronchial aspirates of lung carcinoma patients by polymerase chain reaction: a study of 84 cases in Croatia.

Authors:  Bozica Vrabec Branica; Silvana Smojver-Jezek; Zrinka Juros; Sandra Grgić; Nives Srpak; Dinko Mitrecić; Srećko Gajović
Journal:  Coll Antropol       Date:  2010-03

Review 2.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

3.  EGFR mutations and human papillomavirus in lung cancer.

Authors:  Takuya Kato; Chihaya Koriyama; Noureen Khan; Takuya Samukawa; Masakazu Yanagi; Tsutomu Hamada; Naoya Yokomakura; Takeshi Otsuka; Hiromasa Inoue; Masami Sato; Shoji Natsugoe; Suminori Akiba
Journal:  Lung Cancer       Date:  2012-09-10       Impact factor: 5.705

4.  Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas.

Authors:  Michihiro Baba; Andres Castillo; Chihaya Koriyama; Masakazu Yanagi; Hidehiko Matsumoto; Shoji Natsugoe; Karem Y Shuyama; Noureen Khan; Michiyo Higashi; Tetsuhiko Itoh; Yoshito Eizuru; Takashi Aikou; Suminori Akiba
Journal:  Oncol Rep       Date:  2010-04       Impact factor: 3.906

5.  Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases.

Authors:  Cyrille J Coissard; Guillaume Besson; Myriam C Polette; Michel Monteau; Philippe L Birembaut; Christine E Clavel
Journal:  Mod Pathol       Date:  2005-12       Impact factor: 7.842

6.  Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization.

Authors:  K Syrjänen; S Syrjänen; J Kellokoski; J Kärjä; R Mäntyjärvi
Journal:  Lung       Date:  1989       Impact factor: 2.584

7.  Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.

Authors:  De-Wei Wu; Wen-Shan Liu; John Wang; Chih-Yi Chen; Ya-Wen Cheng; Huei Lee
Journal:  Clin Cancer Res       Date:  2011-02-16       Impact factor: 12.531

8.  The characteristics of human papillomavirus DNA in head and neck cancers and papillomas.

Authors:  T Major; K Szarka; I Sziklai; L Gergely; J Czeglédy
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

9.  Loss of FHIT function in lung cancer and preinvasive bronchial lesions.

Authors:  G Sozzi; U Pastorino; L Moiraghi; E Tagliabue; F Pezzella; C Ghirelli; S Tornielli; L Sard; K Huebner; M A Pierotti; C M Croce; S Pilotti
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

10.  Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.

Authors:  Tomofumi Yohena; Ichiro Yoshino; Tomoyoshi Takenaka; Toshifumi Kameyama; Taro Ohba; Yukio Kuniyoshi; Yoshihiko Maehara
Journal:  J Thorac Oncol       Date:  2009-03       Impact factor: 15.609

View more
  17 in total

1.  Presence and activity of HPV in primary lung cancer.

Authors:  Talita Helena Araujo de Oliveira; Carolina Medeiros do Amaral; Bianca de França São Marcos; Kamylla Conceição Gomes Nascimento; Ana Carine de Miranda Rios; Dafne Carolina Alves Quixabeira; Maria Tereza Cartaxo Muniz; Jacinto da Costa Silva Neto; Antonio Carlos de Freitas
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-17       Impact factor: 4.553

2.  Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients.

Authors:  Yao Wu; Qing Yin; Ya-Ling Zhou; Lei He; Zhi-Qing Zou; Xiao-Yue Dai; Wen Xia
Journal:  Cancer Biol Ther       Date:  2021-02-04       Impact factor: 4.742

3.  No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population.

Authors:  Jeong Eun Lee; Yong-Moon Lee; In-Ock Seong; Min-Woong Kang; Choong Sik Lee; Kyung-Hee Kim
Journal:  Osong Public Health Res Perspect       Date:  2016-10-21

4.  The association between human papillomavirus infection and lung cancer: a system review and meta-analysis.

Authors:  Wei-Min Xiong; Qiu-Ping Xu; Xu Li; Ren-Dong Xiao; Lin Cai; Fei He
Journal:  Oncotarget       Date:  2017-10-09

5.  Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer.

Authors:  Ausra Stumbryte; Zivile Gudleviciene; Gabrielis Kundrotas; Daiva Dabkeviciene; Agne Kunickaite; Saulius Cicenas
Journal:  Oncotarget       Date:  2017-11-29

6.  Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank.

Authors:  Isabelle Stücker; Diane Martin; Monica Neri; Pierre Laurent-Puig; Hélène Blons; Martine Antoine; Anne Guiochon-Mantel; Sylvie Brailly-Tabard; Marianne Canonico; Marie Wislez; Jean Trédaniel
Journal:  BMC Public Health       Date:  2017-04-17       Impact factor: 3.295

7.  Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?

Authors:  Zhenjie Zhuang; Junmao Wen; Lu Zhang; Mingjia Zhang; Xiaoying Zhong; Huiqi Chen; Chuanjin Luo
Journal:  Eur J Integr Med       Date:  2020-05-26       Impact factor: 1.314

Review 8.  An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis and Lung Cancer Treatment.

Authors:  Vianey Rodriguez-Lara; Maria Rosa Avila-Costa
Journal:  Front Med (Lausanne)       Date:  2021-05-17

9.  Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinoma.

Authors:  Xuehai Wang; Gang Li; Qingsong Luo; Jiayong Xie; Chongzhi Gan
Journal:  Cancer Cell Int       Date:  2018-02-22       Impact factor: 5.722

10.  Investigating the role of human papillomavirus in lung cancer.

Authors:  E Argyri; E Tsimplaki; C Marketos; G Politis; E Panotopoulou
Journal:  Papillomavirus Res       Date:  2016-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.